127 related articles for article (PubMed ID: 37439418)
1. Sex-related differences in benefits of anticoagulation therapy in elderly patients with atrial fibrillation: a subanalysis of the EMERG-AF study.
Varona M; Martín A; Sánchez J; Tamargo J; Cancio M; Sánchez S; Carbajosa J; Fernández de Simón A; Ríos J; Del Arco C; Ormaetxe J; Suero C; Coll-Vinent B;
Emergencias; 2023 Aug; 35(4):252-260. PubMed ID: 37439418
[TBL] [Abstract][Full Text] [Related]
2. Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
Coll-Vinent B; Martín A; Sánchez J; Tamargo J; Suero C; Malagón F; Varona M; Cancio M; Sánchez S; Carbajosa J; Ríos J; Casanovas G; Ràfols C; Del Arco C;
Stroke; 2017 May; 48(5):1344-1352. PubMed ID: 28389612
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
4. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
[TBL] [Abstract][Full Text] [Related]
5. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Westenbrink BD; Alings M; Granger CB; Alexander JH; Lopes RD; Hylek EM; Thomas L; Wojdyla DM; Hanna M; Keltai M; Steg PG; De Caterina R; Wallentin L; van Gilst WH
Am Heart J; 2017 Mar; 185():140-149. PubMed ID: 28267467
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
7. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding.
Niaz S; Kirwan C; Clayton N; Mercuri M; de Wit K
CJEM; 2021 May; 23(3):325-329. PubMed ID: 33959927
[TBL] [Abstract][Full Text] [Related]
9. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study.
Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):681-691. PubMed ID: 37580139
[TBL] [Abstract][Full Text] [Related]
11. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
12. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
[TBL] [Abstract][Full Text] [Related]
13. Ninety-Day Stroke or Transient Ischemic Attack Recurrence in Patients Prescribed Anticoagulation in the Emergency Department With Atrial Fibrillation and a New Transient Ischemic Attack or Minor Stroke.
Wilson G; Sharma M; Eagles D; Nemnom MJ; Sivilotti MLA; Émond M; Stiell IG; Stotts G; Lee J; Worster A; Morris J; Cheung KW; Jin AY; Oczkowski WJ; Sahlas DJ; Murray HE; Mackey A; Verreault S; Camden MC; Yip S; Teal P; Gladstone DJ; Boulos MI; Chagnon N; Shouldice E; Atzema C; Slaoui T; Teitlebaum J; Wells GA; Nath A; Perry JJ
J Am Heart Assoc; 2023 Apr; 12(8):e026681. PubMed ID: 37026540
[TBL] [Abstract][Full Text] [Related]
14. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
15. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
17. Hospitalized frail elderly patients - atrial fibrillation, anticoagulation and 12 months' outcomes.
Ekerstad N; Karlsson T; Söderqvist S; Karlson BW
Clin Interv Aging; 2018; 13():749-756. PubMed ID: 29731616
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the recommended prevention of thrombosis in hospitalised patients with atrial fibrillation and high thromboembolism risk.
Gorczyca I; Wożakowska-Kapłon B; Starzyk K; Szpotowicz A; Stec A
Kardiol Pol; 2018; 76(3):625-632. PubMed ID: 29297187
[TBL] [Abstract][Full Text] [Related]
19. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
[TBL] [Abstract][Full Text] [Related]
20. Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall.
Obi CA; Bulsara K; Izard S; Delicce A; Smith A; Kim EJ
J Thromb Thrombolysis; 2022 Apr; 53(3):683-689. PubMed ID: 34480676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]